Alectinib

Alectinib

Another Name
Alecensa、Alecinix、Alecnib、艾乐替尼、阿来替尼
Indications
Alectinib treatment for non-small cell lung cancer.
Reg No
06 L 1127/24
Inspection No
1360-24
dosage form:capsule
Specs:150mg*56 capsules
Indate:24 months
Date：2024-9-1 Views：1180
Drug Info

COMPOSITION:

Each capsule contains Alectinib HCl 161.33 mg equivalent to Alectinib………..150mg.

INDICATION:

LuciAle is a kinase inhibitor indicated for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) as detected by an FDA- approved test.

DOSAGE AND USE:

600 mg orally twice daily. Administer LuciAle with food.

STORAGE:

in a dry place and store at 20°C to 25°C.

MANUFACTURED AND MARKETED BY:

LUCIUS PHARMACEUTICALS(LAO) CO., LTD

No.26, Thongmang village, Xaythany district, Vientiane Capital, Laos

WARNING:

Keep medicine out of reach of Children. Do not administer LuciAle during Pregnancy and Lactation.

Original article, if reprinted, please indicate the link to this article: https://lucius-pharmaceuticals.com/drug/alectinib/

Related News